Novan Inc. | TalkMarkets

Latest Posts

The Biotech Analyst Run Down For Friday, June 12, 2019

Article By: Bret Jensen

Friday, July 12, 2019 9:00 AM EDT

The biotech sector was off nearly one and a half percent in trading yesterday. Investors are waiting to hear the details of the administration’s new initiative to reduce drug prices by pegging.

In this article: FATE, RDHL, NOVN, RYTM

Read

Novan Announces Pricing Of $38.0 Million Offering Of Common Stock And Warrants

Article By: NASDAQ GlobeNewswire

Friday, January 5, 2018 12:31 PM EDT

Novan, Inc. today announced the pricing of the Company's underwritten offering of 10 million shares of its common stock and accompanying warrants to purchase up to 10 million shares of common stock with an exercise price of $4.66.

In this article: NOVN

Read

Premarket Biotech Digest – NOVN Reports Topline Results, INNV Receives New Patent, AIQ Signs Merger Agreement

Article By: KKD Healthcare Analytics

Wednesday, April 12, 2017 9:50 AM EDT

Novan stock skyrocketed as the company reported positive topline results from the Company’s Phase 2 clinical trial with SB208. Alliance HealthCare Services announced signing a definitive merger agreement with Tahoe Investment Group.

In this article: AIQ, PLX, AVEO, BCRX, NBIX, MZOR, NOVN

Read